{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:06:25Z","timestamp":1789103185229,"version":"build-2803163510"},"reference-count":55,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cardiology Research Fund, Sheffield NHS Foundation Trust"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/02wdwnk04","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Biomolecular Research Centre, Sheffield Hallam University"},{"id":[{"id":"https:\/\/ror.org\/019wt1929","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The cardiovascular actions of testosterone remain controversial, particularly regarding the safety of testosterone replacement therapy (TTh) in hypogonadal men. We investigated the effects of sustained supraphysiological testosterone exposure on aortic atherogenesis and cardiac remodelling in the testicular feminised (Tfm) mouse, a model of functional androgen receptor (AR) deficiency. Male Tfm mice and AR-intact XY littermate controls were fed a cholesterol-enriched diet for 28 weeks and received fortnightly intramuscular injections of saline or supraphysiological testosterone, alone or in combination with fulvestrant (oestrogen receptor antagonist) or anastrozole (aromatase inhibitor). Aortic lipid deposition was quantified by Oil Red O staining, while cardiac remodelling was assessed by heart weight, cardiomyocyte cross-sectional area and myocardial gene expression. Supraphysiological testosterone significantly reduced aortic fatty streak formation in Tfm mice compared with saline-treated controls (1.25 \u00b1 0.36% vs. 2.85 \u00b1 0.37%, p &lt; 0.01), an effect preserved following fulvestrant or anastrozole treatment, consistent with mechanisms that do not require classical AR or oestrogen receptor signalling. No additional reduction in aortic lipid deposition was observed in AR-intact XY littermates. In contrast, supraphysiological testosterone increased heart weight, cardiomyocyte size and expression of hypertrophic markers exclusively in XY mice, with no evidence of cardiac remodelling in Tfm mice. Collectively, these findings demonstrate divergent tissue-specific cardiovascular actions of testosterone, whereby supraphysiological exposure promotes AR-dependent cardiac remodelling without conferring additional vascular benefit, supporting maintenance of physiological testosterone concentrations during TTh.<\/jats:p>","DOI":"10.3390\/cells15181633","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:43:16Z","timestamp":1788972196000},"page":"1633","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Supraphysiological Testosterone Differentially Regulates Aortic Atheroma and Cardiac Remodelling in the Testicular Feminised Mouse"],"prefix":"10.3390","volume":"15","author":[{"given":"Daniel M.","family":"Kelly","sequence":"first","affiliation":[{"name":"Biomolecular Research Centre, Sheffield Hallam University, Sheffield S1 1WB, UK"},{"name":"Division of Clinical Medicine, University of Sheffield, Sheffield S10 2RX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E.","family":"Nettleship","sequence":"additional","affiliation":[{"name":"Division of Clinical Medicine, University of Sheffield, Sheffield S10 2RX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta M.","family":"Gillett","sequence":"additional","affiliation":[{"name":"Biomolecular Research Centre, Sheffield Hallam University, Sheffield S1 1WB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Hugh","family":"Jones","sequence":"additional","affiliation":[{"name":"Division of Clinical Medicine, University of Sheffield, Sheffield S10 2RX, UK"},{"name":"Centre for Diabetes and Endocrinology, Barnsley Hospital NHS Foundation Trust, Barnsley S75 2EP, UK"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1530\/JOE-12-0582","article-title":"Testosterone: A Vascular Hormone in Health and Disease","volume":"217","author":"Kelly","year":"2013","journal-title":"J. Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-12-0455","article-title":"Testosterone: A Metabolic Hormone in Health and Disease","volume":"217","author":"Kelly","year":"2013","journal-title":"J. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12020-016-1019-1","article-title":"Testosterone Differentially Regulates Targets of Lipid and Glucose Metabolism in Liver, Muscle and Adipose Tissues of the Testicular Feminised Mouse","volume":"54","author":"Kelly","year":"2016","journal-title":"Endocrine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s42255-025-01431-6","article-title":"Metabolic Messengers: Testosterone","volume":"8","author":"Bhasin","year":"2026","journal-title":"Nat. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Xu, L., Freeman, G., Cowling, B.J., and Schooling, C.M. (2013). Testosterone Therapy and Cardiovascular Events among Men: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Trials. BMC Med., 11.","DOI":"10.1186\/1741-7015-11-108"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Finkle, W.D., Greenland, S., Ridgeway, G.K., Adams, J.L., Frasco, M.A., Cook, M.B., Fraumeni, J.F., and Hoover, R.N. (2014). Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085805"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2014.392","article-title":"Deaths and Cardiovascular Events in Men Receiving Testosterone","volume":"311","author":"Morgentaler","year":"2014","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.mayocp.2014.10.011","article-title":"Testosterone Therapy and Cardiovascular Risk: Advances and Controversies","volume":"90","author":"Morgentaler","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jama.2014.386","article-title":"Deaths and Cardiovascular Events in Men Receiving Testosterone","volume":"311","author":"Riche","year":"2014","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular Safety of Testosterone-Replacement Therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.mayocp.2024.08.008","article-title":"Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy","volume":"99","author":"Morgentaler","year":"2024","journal-title":"Mayo Clin. Proc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/andr.70062","article-title":"Cardiovascular Safety of Testosterone Therapy-Insights from the TRAVERSE Trial and beyond: A Position Statement of the European Expert Panel for Testosterone Research","volume":"14","author":"Zitzmann","year":"2026","journal-title":"Andrology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-13-0321","article-title":"Testosterone Deficiency Is Associated with Increased Risk of Mortality and Testosterone Replacement Improves Survival in Men with Type 2 Diabetes","volume":"169","author":"Muraleedharan","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCHEARTFAILURE.109.931063","article-title":"Long-Term Anabolic-Androgenic Steroid Use Is Associated with Left Ventricular Dysfunction","volume":"3","author":"Baggish","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/euhj.1999.1873","article-title":"Men with Coronary Artery Disease Have Lower Levels of Androgens than Men with Normal Coronary Angiograms","volume":"21","author":"English","year":"2000","journal-title":"Eur. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrendo.2013.122","article-title":"Testosterone and Insulin Resistance in the Metabolic Syndrome and T2DM in Men","volume":"9","author":"Rao","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jacc.2005.01.052","article-title":"Increased Carotid Atherosclerosis in Andropausal Middle-Aged Men","volume":"45","author":"Perheentupa","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/cen.12503","article-title":"Testosterone and Mortality","volume":"81","author":"Muraleedharan","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1136\/hrt.2010.195412","article-title":"Low Serum Testosterone and Increased Mortality in Men with Coronary Heart Disease","volume":"96","author":"Malkin","year":"2010","journal-title":"Heart"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"d3105","DOI":"10.1136\/bmj.d3105","article-title":"Cardiovascular Risk during Androgen Deprivation Therapy for Prostate Cancer","volume":"342","author":"Jones","year":"2011","journal-title":"BMJ"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/07435800.2012.735307","article-title":"Effect of Testosterone on Inflammatory Markers in the Development of Early Atherogenesis in the Testicular-Feminized Mouse Model","volume":"38","author":"Kelly","year":"2013","journal-title":"Endocr. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"106938","DOI":"10.1016\/j.jsbmb.2026.106938","article-title":"Anabolic-Androgenic Steroids at Supraphysiological Doses: Cardiovascular Impacts and Pathophysiological Mechanisms","volume":"258","author":"Nascimento","year":"2026","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1210\/mend-5-4-573","article-title":"A Frameshift Mutation Destabilizes Androgen Receptor Messenger RNA in the Tfm Mouse","volume":"5","author":"Charest","year":"1991","journal-title":"Mol. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1093\/nar\/19.9.2373","article-title":"A Frame-Shift Mutation in the Androgen Receptor Gene Causes Complete Androgen Insensitivity in the Testicular-Feminized Mouse","volume":"19","author":"He","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1677\/joe.0.1310443","article-title":"Testicular Steroidogenesis in the Testicular Feminized (Tfm) Mouse: Loss of 17 Alpha-Hydroxylase Activity","volume":"131","author":"Murphy","year":"1991","journal-title":"J. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1677\/joe.0.1390127","article-title":"Suppressed Expression of the Cytochrome P45017 Alpha Protein in the Testicular Feminized (Tfm) Mouse Testes","volume":"139","author":"Baulieu","year":"1993","journal-title":"J. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1161\/CIRCULATIONAHA.107.708768","article-title":"Physiological Testosterone Replacement Therapy Attenuates Fatty Streak Formation and Improves High-Density Lipoprotein Cholesterol in the Tfm Mouse: An Effect That Is Independent of the Classic Androgen Receptor","volume":"116","author":"Nettleship","year":"2007","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/eje.0.1480111","article-title":"Altered Circulating Hormone Levels, Endothelial Function and Vascular Reactivity in the Testicular Feminised Mouse","volume":"148","author":"Jones","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/01.ATV.17.10.2192","article-title":"Gender-Specific Differences in the Effects of Testosterone and Estrogen on the Development of Atherosclerosis in Rabbits","volume":"17","author":"Bruck","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1210\/en.2010-0663","article-title":"Androgen Receptor-Dependent and Independent Atheroprotection by Testosterone in Male Mice","volume":"151","author":"Bourghardt","year":"2010","journal-title":"Endocrinology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1073\/pnas.051003698","article-title":"Testosterone Inhibits Early Atherogenesis by Conversion to Estradiol: Critical Role of Aromatase","volume":"98","author":"Nathan","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105496","DOI":"10.1016\/j.jsbmb.2019.105496","article-title":"Vascular Mechanisms of Testosterone: The Non-Genomic Point of View","volume":"196","author":"Lorigo","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.bjp.0705141","article-title":"The Vasodilatory Action of Testosterone: A Potassium-Channel Opening or a Calcium Antagonistic Action?","volume":"138","author":"Jones","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"H1301","DOI":"10.1152\/ajpheart.00753.2009","article-title":"Do Androgens Play a Beneficial Role in the Regulation of Vascular Tone? Nongenomic Vascular Effects of Testosterone Metabolites","volume":"298","author":"Stallone","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1210\/en.2009-1048","article-title":"Androgen Receptor-Dependent Activation of Endothelial Nitric Oxide Synthase in Vascular Endothelial Cells: Role of Phosphatidylinositol 3-Kinase\/Akt Pathway","volume":"151","author":"Yu","year":"2010","journal-title":"Endocrinology"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Alves, J.V., da Costa, R.M., Pereira, C.A., Fedoce, A.G., Silva, C.A.A., Carneiro, F.S., Lobato, N.S., and Tostes, R.C. (2020). Supraphysiological Levels of Testosterone Induce Vascular Dysfunction via Activation of the NLRP3 Inflammasome. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01647"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1210\/en.2009-1268","article-title":"Dihydrotestosterone Suppresses Foam Cell Formation and Attenuates Atherosclerosis Development","volume":"151","author":"Qiu","year":"2010","journal-title":"Endocrinology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0006-291X(02)02038-7","article-title":"Testosterone Up-Regulates Scavenger Receptor BI and Stimulates Cholesterol Efflux from Macrophages","volume":"296","author":"Langer","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"119040","DOI":"10.1016\/j.lfs.2021.119040","article-title":"Testosterone Stimulates Cholesterol Clearance from Human Macrophages by Activating LXR\u03b1","volume":"269","author":"Kilby","year":"2021","journal-title":"Life Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/2193-1801-2-214","article-title":"Testosterone-Derived Estradiol Production by Male Endothelium Is Robust and Dependent on P450 Aromatase via Estrogen Receptor Alpha","volume":"2","author":"Villablanca","year":"2013","journal-title":"SpringerPlus"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2017.10.006","article-title":"The Role of Androgen Receptors in Atherosclerosis","volume":"465","author":"Takov","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of Cardiac Hypertrophy by Intracellular Signalling Pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac Hypertrophy: The Good, the Bad, and the Ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.0000018952.70505.F1","article-title":"Glycogen Synthase Kinase-3beta: A Novel Regulator of Cardiac Hypertrophy and Development","volume":"90","author":"Hardt","year":"2002","journal-title":"Circ. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.116.303613","article-title":"The GSK-3 Family as Therapeutic Target for Myocardial Diseases","volume":"116","author":"Lal","year":"2015","journal-title":"Circ. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen Synthase Kinase-3 (GSK3): Regulation, Actions, and Diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1172\/JCI59701","article-title":"Cardiac Natriuretic Peptides Act via P38 MAPK to Induce the Brown Fat Thermogenic Program in Mouse and Human Adipocytes","volume":"122","author":"Bordicchia","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.2337\/db09-0393","article-title":"Natriuretic Peptides\/cGMP\/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity","volume":"58","author":"Miyashita","year":"2009","journal-title":"Diabetes"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40659-021-00328-4","article-title":"Testosterone Activates Glucose Metabolism through AMPK and Androgen Signaling in Cardiomyocyte Hypertrophy","volume":"54","author":"Troncoso","year":"2021","journal-title":"Biol. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/hrt.2003.025783","article-title":"Cardiac Effects of Anabolic Steroids","volume":"90","author":"Payne","year":"2004","journal-title":"Heart"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.124.071117","article-title":"Cardiovascular Disease in Anabolic Androgenic Steroid Users","volume":"151","author":"Heerfordt","year":"2025","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.sxmr.2017.04.001","article-title":"Erythrocytosis Following Testosterone Therapy","volume":"6","author":"Ohlander","year":"2018","journal-title":"Sex. Med. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/18\/1633\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:24:36Z","timestamp":1789100676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/18\/1633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":55,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cells15181633"],"URL":"https:\/\/doi.org\/10.3390\/cells15181633","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}